Search

Your search keyword '"Michielin, Francesca"' showing total 35 results
Start Over Author "Michielin, Francesca" Publisher american association for cancer research (aacr)
35 results on '"Michielin, Francesca"'

1. Supplementary Table S1 from Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma)

Author

Drakaki, Alexandra, primary, Powles, Thomas, primary, Bamias, Aristotelis, primary, Martin-Liberal, Juan, primary, Shin, Sang Joon, primary, Friedlander, Terence, primary, Tosi, Diego, primary, Park, Chandler, primary, Gomez-Roca, Carlos, primary, Joly Lobbedez, Florence, primary, Castellano, Daniel, primary, Morales-Barrera, Rafael, primary, Moreno-Candilejo, Irene, primary, Fléchon, Aude, primary, Yuen, Kobe, primary, Rishipathak, Deepali, primary, DuPree, Kelly, primary, Young, Fiona, primary, Michielin, Francesca, primary, Shemesh, Colby S., primary, Steinberg, Elizabeth E., primary, Williams, Patrick, primary, and Lee, Jae Lyun, primary

Published
2023
Full Text
View/download PDF

2. Supplementary Figure S3 from Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma)

Author

Drakaki, Alexandra, primary, Powles, Thomas, primary, Bamias, Aristotelis, primary, Martin-Liberal, Juan, primary, Shin, Sang Joon, primary, Friedlander, Terence, primary, Tosi, Diego, primary, Park, Chandler, primary, Gomez-Roca, Carlos, primary, Joly Lobbedez, Florence, primary, Castellano, Daniel, primary, Morales-Barrera, Rafael, primary, Moreno-Candilejo, Irene, primary, Fléchon, Aude, primary, Yuen, Kobe, primary, Rishipathak, Deepali, primary, DuPree, Kelly, primary, Young, Fiona, primary, Michielin, Francesca, primary, Shemesh, Colby S., primary, Steinberg, Elizabeth E., primary, Williams, Patrick, primary, and Lee, Jae Lyun, primary

Published
2023
Full Text
View/download PDF

3. Supplementary Figure S4 from Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma)

Author

Drakaki, Alexandra, primary, Powles, Thomas, primary, Bamias, Aristotelis, primary, Martin-Liberal, Juan, primary, Shin, Sang Joon, primary, Friedlander, Terence, primary, Tosi, Diego, primary, Park, Chandler, primary, Gomez-Roca, Carlos, primary, Joly Lobbedez, Florence, primary, Castellano, Daniel, primary, Morales-Barrera, Rafael, primary, Moreno-Candilejo, Irene, primary, Fléchon, Aude, primary, Yuen, Kobe, primary, Rishipathak, Deepali, primary, DuPree, Kelly, primary, Young, Fiona, primary, Michielin, Francesca, primary, Shemesh, Colby S., primary, Steinberg, Elizabeth E., primary, Williams, Patrick, primary, and Lee, Jae Lyun, primary

Published
2023
Full Text
View/download PDF

4. Supplementary Table S2 from Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma)

Author

Drakaki, Alexandra, primary, Powles, Thomas, primary, Bamias, Aristotelis, primary, Martin-Liberal, Juan, primary, Shin, Sang Joon, primary, Friedlander, Terence, primary, Tosi, Diego, primary, Park, Chandler, primary, Gomez-Roca, Carlos, primary, Joly Lobbedez, Florence, primary, Castellano, Daniel, primary, Morales-Barrera, Rafael, primary, Moreno-Candilejo, Irene, primary, Fléchon, Aude, primary, Yuen, Kobe, primary, Rishipathak, Deepali, primary, DuPree, Kelly, primary, Young, Fiona, primary, Michielin, Francesca, primary, Shemesh, Colby S., primary, Steinberg, Elizabeth E., primary, Williams, Patrick, primary, and Lee, Jae Lyun, primary

Published
2023
Full Text
View/download PDF

5. Supplementary Figure S1 from Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma)

Author

Drakaki, Alexandra, primary, Powles, Thomas, primary, Bamias, Aristotelis, primary, Martin-Liberal, Juan, primary, Shin, Sang Joon, primary, Friedlander, Terence, primary, Tosi, Diego, primary, Park, Chandler, primary, Gomez-Roca, Carlos, primary, Joly Lobbedez, Florence, primary, Castellano, Daniel, primary, Morales-Barrera, Rafael, primary, Moreno-Candilejo, Irene, primary, Fléchon, Aude, primary, Yuen, Kobe, primary, Rishipathak, Deepali, primary, DuPree, Kelly, primary, Young, Fiona, primary, Michielin, Francesca, primary, Shemesh, Colby S., primary, Steinberg, Elizabeth E., primary, Williams, Patrick, primary, and Lee, Jae Lyun, primary

Published
2023
Full Text
View/download PDF

6. Supplementary Figure S1 from Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma)

Author

Drakaki, Alexandra, primary, Powles, Thomas, primary, Bamias, Aristotelis, primary, Martin-Liberal, Juan, primary, Shin, Sang Joon, primary, Friedlander, Terence, primary, Tosi, Diego, primary, Park, Chandler, primary, Gomez-Roca, Carlos, primary, Joly Lobbedez, Florence, primary, Castellano, Daniel, primary, Morales-Barrera, Rafael, primary, Moreno-Candilejo, Irene, primary, Fléchon, Aude, primary, Yuen, Kobe, primary, Rishipathak, Deepali, primary, DuPree, Kelly, primary, Young, Fiona, primary, Michielin, Francesca, primary, Shemesh, Colby S., primary, Steinberg, Elizabeth E., primary, Williams, Patrick, primary, and Lee, Jae Lyun, primary

Published
2023
Full Text
View/download PDF

7. Data from Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma)

Author

Drakaki, Alexandra, primary, Powles, Thomas, primary, Bamias, Aristotelis, primary, Martin-Liberal, Juan, primary, Shin, Sang Joon, primary, Friedlander, Terence, primary, Tosi, Diego, primary, Park, Chandler, primary, Gomez-Roca, Carlos, primary, Joly Lobbedez, Florence, primary, Castellano, Daniel, primary, Morales-Barrera, Rafael, primary, Moreno-Candilejo, Irene, primary, Fléchon, Aude, primary, Yuen, Kobe, primary, Rishipathak, Deepali, primary, DuPree, Kelly, primary, Young, Fiona, primary, Michielin, Francesca, primary, Shemesh, Colby S., primary, Steinberg, Elizabeth E., primary, Williams, Patrick, primary, and Lee, Jae Lyun, primary

Published
2023
Full Text
View/download PDF

8. Supplementary Figure S4 from Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma)

Author

Drakaki, Alexandra, primary, Powles, Thomas, primary, Bamias, Aristotelis, primary, Martin-Liberal, Juan, primary, Shin, Sang Joon, primary, Friedlander, Terence, primary, Tosi, Diego, primary, Park, Chandler, primary, Gomez-Roca, Carlos, primary, Joly Lobbedez, Florence, primary, Castellano, Daniel, primary, Morales-Barrera, Rafael, primary, Moreno-Candilejo, Irene, primary, Fléchon, Aude, primary, Yuen, Kobe, primary, Rishipathak, Deepali, primary, DuPree, Kelly, primary, Young, Fiona, primary, Michielin, Francesca, primary, Shemesh, Colby S., primary, Steinberg, Elizabeth E., primary, Williams, Patrick, primary, and Lee, Jae Lyun, primary

Published
2023
Full Text
View/download PDF

9. Supplementary Table S7 from Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma)

Author

Drakaki, Alexandra, primary, Powles, Thomas, primary, Bamias, Aristotelis, primary, Martin-Liberal, Juan, primary, Shin, Sang Joon, primary, Friedlander, Terence, primary, Tosi, Diego, primary, Park, Chandler, primary, Gomez-Roca, Carlos, primary, Joly Lobbedez, Florence, primary, Castellano, Daniel, primary, Morales-Barrera, Rafael, primary, Moreno-Candilejo, Irene, primary, Fléchon, Aude, primary, Yuen, Kobe, primary, Rishipathak, Deepali, primary, DuPree, Kelly, primary, Young, Fiona, primary, Michielin, Francesca, primary, Shemesh, Colby S., primary, Steinberg, Elizabeth E., primary, Williams, Patrick, primary, and Lee, Jae Lyun, primary

Published
2023
Full Text
View/download PDF

10. Supplementary Figure S2 from Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma)

Author

Drakaki, Alexandra, primary, Powles, Thomas, primary, Bamias, Aristotelis, primary, Martin-Liberal, Juan, primary, Shin, Sang Joon, primary, Friedlander, Terence, primary, Tosi, Diego, primary, Park, Chandler, primary, Gomez-Roca, Carlos, primary, Joly Lobbedez, Florence, primary, Castellano, Daniel, primary, Morales-Barrera, Rafael, primary, Moreno-Candilejo, Irene, primary, Fléchon, Aude, primary, Yuen, Kobe, primary, Rishipathak, Deepali, primary, DuPree, Kelly, primary, Young, Fiona, primary, Michielin, Francesca, primary, Shemesh, Colby S., primary, Steinberg, Elizabeth E., primary, Williams, Patrick, primary, and Lee, Jae Lyun, primary

Published
2023
Full Text
View/download PDF

11. Supplementary Table S3 from Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma)

Author

Drakaki, Alexandra, primary, Powles, Thomas, primary, Bamias, Aristotelis, primary, Martin-Liberal, Juan, primary, Shin, Sang Joon, primary, Friedlander, Terence, primary, Tosi, Diego, primary, Park, Chandler, primary, Gomez-Roca, Carlos, primary, Joly Lobbedez, Florence, primary, Castellano, Daniel, primary, Morales-Barrera, Rafael, primary, Moreno-Candilejo, Irene, primary, Fléchon, Aude, primary, Yuen, Kobe, primary, Rishipathak, Deepali, primary, DuPree, Kelly, primary, Young, Fiona, primary, Michielin, Francesca, primary, Shemesh, Colby S., primary, Steinberg, Elizabeth E., primary, Williams, Patrick, primary, and Lee, Jae Lyun, primary

Published
2023
Full Text
View/download PDF

12. Supplementary Table S5 from Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma)

Author

Drakaki, Alexandra, primary, Powles, Thomas, primary, Bamias, Aristotelis, primary, Martin-Liberal, Juan, primary, Shin, Sang Joon, primary, Friedlander, Terence, primary, Tosi, Diego, primary, Park, Chandler, primary, Gomez-Roca, Carlos, primary, Joly Lobbedez, Florence, primary, Castellano, Daniel, primary, Morales-Barrera, Rafael, primary, Moreno-Candilejo, Irene, primary, Fléchon, Aude, primary, Yuen, Kobe, primary, Rishipathak, Deepali, primary, DuPree, Kelly, primary, Young, Fiona, primary, Michielin, Francesca, primary, Shemesh, Colby S., primary, Steinberg, Elizabeth E., primary, Williams, Patrick, primary, and Lee, Jae Lyun, primary

Published
2023
Full Text
View/download PDF

13. Supplementary Table S7 from Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma)

Author

Drakaki, Alexandra, primary, Powles, Thomas, primary, Bamias, Aristotelis, primary, Martin-Liberal, Juan, primary, Shin, Sang Joon, primary, Friedlander, Terence, primary, Tosi, Diego, primary, Park, Chandler, primary, Gomez-Roca, Carlos, primary, Joly Lobbedez, Florence, primary, Castellano, Daniel, primary, Morales-Barrera, Rafael, primary, Moreno-Candilejo, Irene, primary, Fléchon, Aude, primary, Yuen, Kobe, primary, Rishipathak, Deepali, primary, DuPree, Kelly, primary, Young, Fiona, primary, Michielin, Francesca, primary, Shemesh, Colby S., primary, Steinberg, Elizabeth E., primary, Williams, Patrick, primary, and Lee, Jae Lyun, primary

Published
2023
Full Text
View/download PDF

14. Supplementary Table S6 from Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma)

Author

Drakaki, Alexandra, primary, Powles, Thomas, primary, Bamias, Aristotelis, primary, Martin-Liberal, Juan, primary, Shin, Sang Joon, primary, Friedlander, Terence, primary, Tosi, Diego, primary, Park, Chandler, primary, Gomez-Roca, Carlos, primary, Joly Lobbedez, Florence, primary, Castellano, Daniel, primary, Morales-Barrera, Rafael, primary, Moreno-Candilejo, Irene, primary, Fléchon, Aude, primary, Yuen, Kobe, primary, Rishipathak, Deepali, primary, DuPree, Kelly, primary, Young, Fiona, primary, Michielin, Francesca, primary, Shemesh, Colby S., primary, Steinberg, Elizabeth E., primary, Williams, Patrick, primary, and Lee, Jae Lyun, primary

Published
2023
Full Text
View/download PDF

15. Supplementary Table S2 from Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma)

Author

Drakaki, Alexandra, primary, Powles, Thomas, primary, Bamias, Aristotelis, primary, Martin-Liberal, Juan, primary, Shin, Sang Joon, primary, Friedlander, Terence, primary, Tosi, Diego, primary, Park, Chandler, primary, Gomez-Roca, Carlos, primary, Joly Lobbedez, Florence, primary, Castellano, Daniel, primary, Morales-Barrera, Rafael, primary, Moreno-Candilejo, Irene, primary, Fléchon, Aude, primary, Yuen, Kobe, primary, Rishipathak, Deepali, primary, DuPree, Kelly, primary, Young, Fiona, primary, Michielin, Francesca, primary, Shemesh, Colby S., primary, Steinberg, Elizabeth E., primary, Williams, Patrick, primary, and Lee, Jae Lyun, primary

Published
2023
Full Text
View/download PDF

16. Supplementary Table S4 from Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma)

Author

Drakaki, Alexandra, primary, Powles, Thomas, primary, Bamias, Aristotelis, primary, Martin-Liberal, Juan, primary, Shin, Sang Joon, primary, Friedlander, Terence, primary, Tosi, Diego, primary, Park, Chandler, primary, Gomez-Roca, Carlos, primary, Joly Lobbedez, Florence, primary, Castellano, Daniel, primary, Morales-Barrera, Rafael, primary, Moreno-Candilejo, Irene, primary, Fléchon, Aude, primary, Yuen, Kobe, primary, Rishipathak, Deepali, primary, DuPree, Kelly, primary, Young, Fiona, primary, Michielin, Francesca, primary, Shemesh, Colby S., primary, Steinberg, Elizabeth E., primary, Williams, Patrick, primary, and Lee, Jae Lyun, primary

Published
2023
Full Text
View/download PDF

17. Supplementary Figure S3 from Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma)

Author

Drakaki, Alexandra, primary, Powles, Thomas, primary, Bamias, Aristotelis, primary, Martin-Liberal, Juan, primary, Shin, Sang Joon, primary, Friedlander, Terence, primary, Tosi, Diego, primary, Park, Chandler, primary, Gomez-Roca, Carlos, primary, Joly Lobbedez, Florence, primary, Castellano, Daniel, primary, Morales-Barrera, Rafael, primary, Moreno-Candilejo, Irene, primary, Fléchon, Aude, primary, Yuen, Kobe, primary, Rishipathak, Deepali, primary, DuPree, Kelly, primary, Young, Fiona, primary, Michielin, Francesca, primary, Shemesh, Colby S., primary, Steinberg, Elizabeth E., primary, Williams, Patrick, primary, and Lee, Jae Lyun, primary

Published
2023
Full Text
View/download PDF

18. Supplementary Table S3 from Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma)

Author

Drakaki, Alexandra, primary, Powles, Thomas, primary, Bamias, Aristotelis, primary, Martin-Liberal, Juan, primary, Shin, Sang Joon, primary, Friedlander, Terence, primary, Tosi, Diego, primary, Park, Chandler, primary, Gomez-Roca, Carlos, primary, Joly Lobbedez, Florence, primary, Castellano, Daniel, primary, Morales-Barrera, Rafael, primary, Moreno-Candilejo, Irene, primary, Fléchon, Aude, primary, Yuen, Kobe, primary, Rishipathak, Deepali, primary, DuPree, Kelly, primary, Young, Fiona, primary, Michielin, Francesca, primary, Shemesh, Colby S., primary, Steinberg, Elizabeth E., primary, Williams, Patrick, primary, and Lee, Jae Lyun, primary

Published
2023
Full Text
View/download PDF

19. Supplementary Table S5 from Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma)

Author

Drakaki, Alexandra, primary, Powles, Thomas, primary, Bamias, Aristotelis, primary, Martin-Liberal, Juan, primary, Shin, Sang Joon, primary, Friedlander, Terence, primary, Tosi, Diego, primary, Park, Chandler, primary, Gomez-Roca, Carlos, primary, Joly Lobbedez, Florence, primary, Castellano, Daniel, primary, Morales-Barrera, Rafael, primary, Moreno-Candilejo, Irene, primary, Fléchon, Aude, primary, Yuen, Kobe, primary, Rishipathak, Deepali, primary, DuPree, Kelly, primary, Young, Fiona, primary, Michielin, Francesca, primary, Shemesh, Colby S., primary, Steinberg, Elizabeth E., primary, Williams, Patrick, primary, and Lee, Jae Lyun, primary

Published
2023
Full Text
View/download PDF

20. Supplementary Table S4 from Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma)

Author

Drakaki, Alexandra, primary, Powles, Thomas, primary, Bamias, Aristotelis, primary, Martin-Liberal, Juan, primary, Shin, Sang Joon, primary, Friedlander, Terence, primary, Tosi, Diego, primary, Park, Chandler, primary, Gomez-Roca, Carlos, primary, Joly Lobbedez, Florence, primary, Castellano, Daniel, primary, Morales-Barrera, Rafael, primary, Moreno-Candilejo, Irene, primary, Fléchon, Aude, primary, Yuen, Kobe, primary, Rishipathak, Deepali, primary, DuPree, Kelly, primary, Young, Fiona, primary, Michielin, Francesca, primary, Shemesh, Colby S., primary, Steinberg, Elizabeth E., primary, Williams, Patrick, primary, and Lee, Jae Lyun, primary

Published
2023
Full Text
View/download PDF

21. Data from Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma)

Author

Drakaki, Alexandra, primary, Powles, Thomas, primary, Bamias, Aristotelis, primary, Martin-Liberal, Juan, primary, Shin, Sang Joon, primary, Friedlander, Terence, primary, Tosi, Diego, primary, Park, Chandler, primary, Gomez-Roca, Carlos, primary, Joly Lobbedez, Florence, primary, Castellano, Daniel, primary, Morales-Barrera, Rafael, primary, Moreno-Candilejo, Irene, primary, Fléchon, Aude, primary, Yuen, Kobe, primary, Rishipathak, Deepali, primary, DuPree, Kelly, primary, Young, Fiona, primary, Michielin, Francesca, primary, Shemesh, Colby S., primary, Steinberg, Elizabeth E., primary, Williams, Patrick, primary, and Lee, Jae Lyun, primary

Published
2023
Full Text
View/download PDF

22. Supplementary Table S6 from Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma)

Author

Drakaki, Alexandra, primary, Powles, Thomas, primary, Bamias, Aristotelis, primary, Martin-Liberal, Juan, primary, Shin, Sang Joon, primary, Friedlander, Terence, primary, Tosi, Diego, primary, Park, Chandler, primary, Gomez-Roca, Carlos, primary, Joly Lobbedez, Florence, primary, Castellano, Daniel, primary, Morales-Barrera, Rafael, primary, Moreno-Candilejo, Irene, primary, Fléchon, Aude, primary, Yuen, Kobe, primary, Rishipathak, Deepali, primary, DuPree, Kelly, primary, Young, Fiona, primary, Michielin, Francesca, primary, Shemesh, Colby S., primary, Steinberg, Elizabeth E., primary, Williams, Patrick, primary, and Lee, Jae Lyun, primary

Published
2023
Full Text
View/download PDF

23. Supplementary Table S1 from Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma)

Author

Drakaki, Alexandra, primary, Powles, Thomas, primary, Bamias, Aristotelis, primary, Martin-Liberal, Juan, primary, Shin, Sang Joon, primary, Friedlander, Terence, primary, Tosi, Diego, primary, Park, Chandler, primary, Gomez-Roca, Carlos, primary, Joly Lobbedez, Florence, primary, Castellano, Daniel, primary, Morales-Barrera, Rafael, primary, Moreno-Candilejo, Irene, primary, Fléchon, Aude, primary, Yuen, Kobe, primary, Rishipathak, Deepali, primary, DuPree, Kelly, primary, Young, Fiona, primary, Michielin, Francesca, primary, Shemesh, Colby S., primary, Steinberg, Elizabeth E., primary, Williams, Patrick, primary, and Lee, Jae Lyun, primary

Published
2023
Full Text
View/download PDF

24. Supplementary Figure S2 from Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma)

Author

Drakaki, Alexandra, primary, Powles, Thomas, primary, Bamias, Aristotelis, primary, Martin-Liberal, Juan, primary, Shin, Sang Joon, primary, Friedlander, Terence, primary, Tosi, Diego, primary, Park, Chandler, primary, Gomez-Roca, Carlos, primary, Joly Lobbedez, Florence, primary, Castellano, Daniel, primary, Morales-Barrera, Rafael, primary, Moreno-Candilejo, Irene, primary, Fléchon, Aude, primary, Yuen, Kobe, primary, Rishipathak, Deepali, primary, DuPree, Kelly, primary, Young, Fiona, primary, Michielin, Francesca, primary, Shemesh, Colby S., primary, Steinberg, Elizabeth E., primary, Williams, Patrick, primary, and Lee, Jae Lyun, primary

Published
2023
Full Text
View/download PDF

25. Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma)

Author

Drakaki, Alexandra, primary, Powles, Thomas, additional, Bamias, Aristotelis, additional, Martin-Liberal, Juan, additional, Shin, Sang Joon, additional, Friedlander, Terence, additional, Tosi, Diego, additional, Park, Chandler, additional, Gomez-Roca, Carlos, additional, Joly Lobbedez, Florence, additional, Castellano, Daniel, additional, Morales-Barrera, Rafael, additional, Moreno-Candilejo, Irene, additional, Fléchon, Aude, additional, Yuen, Kobe, additional, Rishipathak, Deepali, additional, DuPree, Kelly, additional, Young, Fiona, additional, Michielin, Francesca, additional, Shemesh, Colby S., additional, Steinberg, Elizabeth E., additional, Williams, Patrick, additional, and Lee, Jae Lyun, additional

Published
2023
Full Text
View/download PDF

26. Supplementary Figures S1-S2 and Full unedited western blots from Mechanistic Investigations of Diarrhea Toxicity Induced by Anti-HER2/3 Combination Therapy

Author

Moisan, Annie, primary, Michielin, Francesca, primary, Jacob, Wolfgang, primary, Kronenberg, Sven, primary, Wilson, Sabine, primary, Avignon, Blandine, primary, Gérard, Régine, primary, Benmansour, Fethallah, primary, McIntyre, Christine, primary, Meneses-Lorente, Georgina, primary, Hasmann, Max, primary, Schneeweiss, Andreas, primary, Weisser, Martin, primary, and Adessi, Céline, primary

Published
2023
Full Text
View/download PDF

27. Data from Mechanistic Investigations of Diarrhea Toxicity Induced by Anti-HER2/3 Combination Therapy

Author

Moisan, Annie, primary, Michielin, Francesca, primary, Jacob, Wolfgang, primary, Kronenberg, Sven, primary, Wilson, Sabine, primary, Avignon, Blandine, primary, Gérard, Régine, primary, Benmansour, Fethallah, primary, McIntyre, Christine, primary, Meneses-Lorente, Georgina, primary, Hasmann, Max, primary, Schneeweiss, Andreas, primary, Weisser, Martin, primary, and Adessi, Céline, primary

Published
2023
Full Text
View/download PDF

28. Supplementary Figures S1-S2 and Full unedited western blots from Mechanistic Investigations of Diarrhea Toxicity Induced by Anti-HER2/3 Combination Therapy

Author

Moisan, Annie, primary, Michielin, Francesca, primary, Jacob, Wolfgang, primary, Kronenberg, Sven, primary, Wilson, Sabine, primary, Avignon, Blandine, primary, Gérard, Régine, primary, Benmansour, Fethallah, primary, McIntyre, Christine, primary, Meneses-Lorente, Georgina, primary, Hasmann, Max, primary, Schneeweiss, Andreas, primary, Weisser, Martin, primary, and Adessi, Céline, primary

Published
2023
Full Text
View/download PDF

29. Table S1, Table S2 from Phase Ib Study of Lumretuzumab Plus Cetuximab or Erlotinib in Solid Tumor Patients and Evaluation of HER3 and Heregulin as Potential Biomarkers of Clinical Activity

Author

Meulendijks, Didier, primary, Jacob, Wolfgang, primary, Voest, Emile E., primary, Mau-Sorensen, Morten, primary, Martinez-Garcia, Maria, primary, Taus, Alvaro, primary, Fleitas, Tania, primary, Cervantes, Andres, primary, Lolkema, Martijn P., primary, Langenberg, Marlies H.G., primary, De Jonge, Maja J., primary, Sleijfer, Stefan, primary, Han, Ji-Youn, primary, Calles, Antonio, primary, Felip, Enriqueta, primary, Kim, Sang-We, primary, Schellens, Jan H.M., primary, Wilson, Sabine, primary, Thomas, Marlene, primary, Ceppi, Maurizio, primary, Meneses-Lorente, Georgina, primary, James, Ian, primary, Vega-Harring, Suzana, primary, Dua, Rajiv, primary, Nguyen, Maitram, primary, Steiner, Lori, primary, Adessi, Celine, primary, Michielin, Francesca, primary, Bossenmaier, Birgit, primary, Weisser, Martin, primary, and Lassen, Ulrik N., primary

Published
2023
Full Text
View/download PDF

30. Figure S1, Figure S2, Figure S3, Figure S4, Figure S5, Figure S6 from Phase Ib Study of Lumretuzumab Plus Cetuximab or Erlotinib in Solid Tumor Patients and Evaluation of HER3 and Heregulin as Potential Biomarkers of Clinical Activity

Author

Meulendijks, Didier, primary, Jacob, Wolfgang, primary, Voest, Emile E., primary, Mau-Sorensen, Morten, primary, Martinez-Garcia, Maria, primary, Taus, Alvaro, primary, Fleitas, Tania, primary, Cervantes, Andres, primary, Lolkema, Martijn P., primary, Langenberg, Marlies H.G., primary, De Jonge, Maja J., primary, Sleijfer, Stefan, primary, Han, Ji-Youn, primary, Calles, Antonio, primary, Felip, Enriqueta, primary, Kim, Sang-We, primary, Schellens, Jan H.M., primary, Wilson, Sabine, primary, Thomas, Marlene, primary, Ceppi, Maurizio, primary, Meneses-Lorente, Georgina, primary, James, Ian, primary, Vega-Harring, Suzana, primary, Dua, Rajiv, primary, Nguyen, Maitram, primary, Steiner, Lori, primary, Adessi, Celine, primary, Michielin, Francesca, primary, Bossenmaier, Birgit, primary, Weisser, Martin, primary, and Lassen, Ulrik N., primary

Published
2023
Full Text
View/download PDF

31. Supplementary Figure 1, Figure 2, Table 1, Table 2, Table 3, Table 4, Table 5, Table 6 from First-in-Human Phase I Study of Lumretuzumab, a Glycoengineered Humanized Anti-HER3 Monoclonal Antibody, in Patients with Metastatic or Advanced HER3-Positive Solid Tumors

Author

Meulendijks, Didier, primary, Jacob, Wolfgang, primary, Martinez-Garcia, Maria, primary, Taus, Alvaro, primary, Lolkema, Martijn P., primary, Voest, Emile E., primary, Langenberg, Marlies H.G., primary, Fleitas Kanonnikoff, Tania, primary, Cervantes, Andres, primary, De Jonge, Maja J., primary, Sleijfer, Stefan, primary, Soerensen, Morten Mau, primary, Thomas, Marlene, primary, Ceppi, Maurizio, primary, Meneses-Lorente, Georgina, primary, James, Ian, primary, Adessi, Celine, primary, Michielin, Francesca, primary, Abiraj, Keelara, primary, Bossenmaier, Birgit, primary, Schellens, Jan H.M., primary, Weisser, Martin, primary, and Lassen, Ulrik N., primary

Published
2023
Full Text
View/download PDF

32. Figure 1, Figure 2, Table 1, Table 2, Table 3, Table 4, Table 5, Table 6 from First-in-Human Phase I Study of Lumretuzumab, a Glycoengineered Humanized Anti-HER3 Monoclonal Antibody, in Patients with Metastatic or Advanced HER3-Positive Solid Tumors

Author

Meulendijks, Didier, primary, Jacob, Wolfgang, primary, Martinez-Garcia, Maria, primary, Taus, Alvaro, primary, Lolkema, Martijn P., primary, Voest, Emile E., primary, Langenberg, Marlies H.G., primary, Fleitas Kanonnikoff, Tania, primary, Cervantes, Andres, primary, De Jonge, Maja J., primary, Sleijfer, Stefan, primary, Soerensen, Morten Mau, primary, Thomas, Marlene, primary, Ceppi, Maurizio, primary, Meneses-Lorente, Georgina, primary, James, Ian, primary, Adessi, Celine, primary, Michielin, Francesca, primary, Abiraj, Keelara, primary, Bossenmaier, Birgit, primary, Schellens, Jan H.M., primary, Weisser, Martin, primary, and Lassen, Ulrik N., primary

Published
2023
Full Text
View/download PDF

33. Mechanistic Investigations of Diarrhea Toxicity Induced by Anti-HER2/3 Combination Therapy

Author

Moisan, Annie, primary, Michielin, Francesca, additional, Jacob, Wolfgang, additional, Kronenberg, Sven, additional, Wilson, Sabine, additional, Avignon, Blandine, additional, Gérard, Régine, additional, Benmansour, Fethallah, additional, McIntyre, Christine, additional, Meneses-Lorente, Georgina, additional, Hasmann, Max, additional, Schneeweiss, Andreas, additional, Weisser, Martin, additional, and Adessi, Céline, additional

Published
2018
Full Text
View/download PDF

34. Phase Ib Study of Lumretuzumab Plus Cetuximab or Erlotinib in Solid Tumor Patients and Evaluation of HER3 and Heregulin as Potential Biomarkers of Clinical Activity

Author

Meulendijks, Didier, primary, Jacob, Wolfgang, additional, Voest, Emile E., additional, Mau-Sorensen, Morten, additional, Martinez-Garcia, Maria, additional, Taus, Alvaro, additional, Fleitas, Tania, additional, Cervantes, Andres, additional, Lolkema, Martijn P., additional, Langenberg, Marlies H.G., additional, De Jonge, Maja J., additional, Sleijfer, Stefan, additional, Han, Ji-Youn, additional, Calles, Antonio, additional, Felip, Enriqueta, additional, Kim, Sang-We, additional, Schellens, Jan H.M., additional, Wilson, Sabine, additional, Thomas, Marlene, additional, Ceppi, Maurizio, additional, Meneses-Lorente, Georgina, additional, James, Ian, additional, Vega-Harring, Suzana, additional, Dua, Rajiv, additional, Nguyen, Maitram, additional, Steiner, Lori, additional, Adessi, Celine, additional, Michielin, Francesca, additional, Bossenmaier, Birgit, additional, Weisser, Martin, additional, and Lassen, Ulrik N., additional

Published
2017
Full Text
View/download PDF

35. First-in-Human Phase I Study of Lumretuzumab, a Glycoengineered Humanized Anti-HER3 Monoclonal Antibody, in Patients with Metastatic or Advanced HER3-Positive Solid Tumors

Author

Meulendijks, Didier, primary, Jacob, Wolfgang, additional, Martinez-Garcia, Maria, additional, Taus, Alvaro, additional, Lolkema, Martijn P., additional, Voest, Emile E., additional, Langenberg, Marlies H.G., additional, Fleitas Kanonnikoff, Tania, additional, Cervantes, Andres, additional, De Jonge, Maja J., additional, Sleijfer, Stefan, additional, Soerensen, Morten Mau, additional, Thomas, Marlene, additional, Ceppi, Maurizio, additional, Meneses-Lorente, Georgina, additional, James, Ian, additional, Adessi, Celine, additional, Michielin, Francesca, additional, Abiraj, Keelara, additional, Bossenmaier, Birgit, additional, Schellens, Jan H.M., additional, Weisser, Martin, additional, and Lassen, Ulrik N., additional

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results